Rituximab Therapy Effective For ANCA-Associated Vasculitis RedOrbit In an article published today in the New England Journal of Medicine, Immune Tolerance Network (ITN) researchers demonstrated that a single course of rituximab therapy (anti-CD20; Rituxan, Genentech, Inc.) is as effective as the current standard of ... Rituximab Equally Effective for Remission of Vasculitis Rituximab noninferior to conventional therapy in ANCA-associated vasculitis ... Therapy for Severe Vasculitis Shows Long-Term Effectiveness |
